Crossref
CIRCULATING TUMOR DNA AS A PROGNOSTIC BIOMARKER FOR SURVEILLANCE IN PATIENTS WITH RESECTED PANCREATIC DUCTAL ADENOCARCINOMA
HPB · 2026 · 28 · S148
DOI: 10.1016/j.hpb.2026.04.249 ↗Kurz gefasst
Fachartikel in der Zeitschrift HPB, 2026. Verfasst von S. Logarajah und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Logarajah, S., Jomy, A., Fernando, L., Neuwirth, C., Khayat, Madhurapantula, R., Sharma, S., Subramaniam, S., Jurdi, A., Liu, M., & Jeyarajah, D. (2026). CIRCULATING TUMOR DNA AS A PROGNOSTIC BIOMARKER FOR SURVEILLANCE IN PATIENTS WITH RESECTED PANCREATIC DUCTAL ADENOCARCINOMA. HPB, 28, S148. https://doi.org/10.1016/j.hpb.2026.04.249
Vancouver
Logarajah S, Jomy A, Fernando L, Neuwirth C, Khayat, Madhurapantula R, et al. CIRCULATING TUMOR DNA AS A PROGNOSTIC BIOMARKER FOR SURVEILLANCE IN PATIENTS WITH RESECTED PANCREATIC DUCTAL ADENOCARCINOMA. HPB. 2026;28:S148. doi:10.1016/j.hpb.2026.04.249
BibTeX
@article{Logarajah2026,
author = {Logarajah, S. and Jomy, A. and Fernando, L. and Neuwirth, C. and Khayat and Madhurapantula, R.S. and Sharma, S. and Subramaniam, S. and Jurdi, A. and Liu, M.C. and Jeyarajah, D.R.},
title = {CIRCULATING TUMOR DNA AS A PROGNOSTIC BIOMARKER FOR SURVEILLANCE IN PATIENTS WITH RESECTED PANCREATIC DUCTAL ADENOCARCINOMA},
journal = {HPB},
year = {2026},
volume = {28},
pages = {S148},
doi = {10.1016/j.hpb.2026.04.249}
}
EUVIMED